Many-to-one comparisons after safety selection in multi-arm clinical trials.
Ontology highlight
ABSTRACT: In phase II platform trials, 'many-to-one' comparisons are performed when K experimental treatments are compared with a common control to identify the most promising treatment(s) to be selected for Phase III trials. However, when sample sizes are limited, such as when the disease of interest is rare, only a single Phase II/III trial addressing both treatment selection and confirmatory efficacy testing may be feasible. In this paper, we suggest a two-step safety selection and testing procedure for such seamless trials. At the end of the study, treatments are first screened on the basis of safety, and those deemed to be sufficiently safe are then taken forwards for efficacy testing against a common control. All safety and efficacy evaluations are therefore performed at the end of the study,
SUBMITTER: Hlavin G
PROVIDER: S-EPMC5484516 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA